Rapid affinity prediction and fine-tuning

Absidian Bio is a discovery-stage biotechnology company empowering therapeutic antibody AI.

Get in touch
3D model of an antibody docked to its target protein, with the contact residues highlighted

Our approach

Integrate foundations

Our predecessors developed powerful wet lab and computational technologies for understanding antibodies. We leverage across these techniques to produce the data we need for high quality antibody discovery, affinity fine-tuning, and to train our antibody AI.

No shoehorning

Antibodies are fundamentally different than other proteins and we think they deserve dedicated AI models built with antibody data for antibody data.

Data, data, data

We are focused on building a dataset of antibody structures and affinities. As our data grows, so does our ability to generate drugs.

Interested in partnering, investing, or joining us?

We'd be glad to hear from you.